Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 8151-8200 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06628453
CGM for Management of Type 2 Diabetes in Pregnancy
NARecruiting
564 participants
Started: Apr 8, 2025 · Completed: Jul 31, 2029
2 conditions3 sponsors7 locations
NCT06984367
A Socio-Technological Intervention in Community-Based Healthcare for Individuals With Mild Cognitive Impairment (DHEAL-COM-MCI)
NARecruiting
60 participants
Started: Apr 8, 2025 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT06769594
Next Generation CT System
N/ARecruiting
100 participants
Started: Apr 8, 2025 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05968703
Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease
NARecruiting
10 participants
Started: Apr 8, 2025 · Completed: Jul 31, 2027
2 conditions2 sponsors1 location
NCT06747455
BCG for Therapeutic Use Phase Ⅲ Clinical Trial
PHASE3Recruiting
438 participants
Started: Apr 8, 2025 · Completed: Dec 31, 2028
1 condition1 sponsor36 locations
NCT06920433
UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus
EARLY_PHASE1Recruiting
18 participants
Started: Apr 8, 2025 · Completed: Nov 30, 2027
1 condition2 sponsors1 location
NCT06840535
A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer
PHASE1Recruiting
20 participants
Started: Apr 8, 2025 · Completed: Dec 31, 2025
3 conditions1 sponsor3 locations
NCT06515730
Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction
PHASE4Recruiting
212 participants
Started: Apr 8, 2025 · Completed: Jul 1, 2028
2 conditions5 sponsors16 locations
NCT06910709
Single and Multiple Ascending Dose Study of AMG 378 in Healthy Participants
PHASE1Recruiting
92 participants
Started: Apr 8, 2025 · Completed: Oct 4, 2028
1 condition1 sponsor2 locations
NCT06916143
Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made Available in the Body, Alone and in the Presence of a Drug That Reduces Stomach Acid
PHASE1Recruiting
48 participants
Started: Apr 8, 2025 · Completed: Jan 31, 2026
1 condition1 sponsor2 locations
NCT06841328
Fertility Enhancement Through Regenerative Treatment in Ovaries and Testes
N/ARecruiting
60 participants
Started: Apr 8, 2025 · Completed: Apr 30, 2028
6 conditions1 sponsor1 location
NCT06897241
Personalized Metabolic Responses to Rapid, Slow and Resistant Starch
NARecruiting
96 participants
Started: Apr 8, 2025 · Completed: May 1, 2026
1 condition3 sponsors1 location
NCT06913777
Neoadjuvant SNF Precision Therapy Phase III
PHASE3Recruiting
404 participants
Started: Apr 8, 2025 · Completed: Apr 15, 2027
1 condition1 sponsor1 location
NCT06867289
Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring
NARecruiting
50 participants
Started: Apr 8, 2025 · Completed: Apr 8, 2026
2 conditions1 sponsor1 location
NCT06885879
Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma
N/ARecruiting
15 participants
Started: Apr 8, 2025 · Completed: Jul 31, 2028
1 condition1 sponsor1 location
NCT06887335
Deep Sedation With Pre-emptive Endotracheal Intubation for Advanced Bronchoscopy Procedures
N/ARecruiting
203 participants
Started: Apr 8, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06399991
Aligning Facility Leadership and Climate to Advance Mental Health Services Integration in Malawi
NARecruiting
1,080 participants
Started: Apr 8, 2025 · Completed: Sep 30, 2027
2 conditions2 sponsors12 locations
NCT05407987
Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)
PHASE3Recruiting
82 participants
Started: Apr 8, 2025 · Completed: Dec 30, 2026
3 conditions1 sponsor1 location
NCT06740747
Intermittent Theta-Burst Stimulation to Improve Negative Symptoms and Cognition in Schizophrenia
NARecruiting
60 participants
Started: Apr 8, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06810076
Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care
NARecruiting
2,000 participants
Started: Apr 8, 2025 · Completed: Oct 2, 2026
6 conditions3 sponsors1 location
NCT06802081
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
PHASE2Recruiting
100 participants
Started: Apr 8, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06946615
Exploratory Clinical Study of Claudin18.2-Targeted CAR-DC and CAR-T Therapy in Advanced Colorectal Cancer
PHASE1Recruiting
18 participants
Started: Apr 8, 2025 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT06891300
Understanding and Treating Suicidal Ideation With Ketamine
PHASE2/PHASE3Recruiting
36 participants
Started: Apr 8, 2025 · Completed: Oct 31, 2026
2 conditions1 sponsor1 location
NCT06964373
Cervical Ripening Balloons for Same-Day Cervical Prep
NARecruiting
70 participants
Started: Apr 8, 2025 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06621251
Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosthetic Joint Infection
PHASE2Recruiting
60 participants
Started: Apr 8, 2025 · Completed: Nov 30, 2026
2 conditions1 sponsor17 locations
NCT06869837
EOIPB in Laparoscopic Cholecystectomy: Impact on Opioid Consumption Guided by ANI and Analgesia Quality
NARecruiting
80 participants
Started: Apr 8, 2025 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT05835973
Evaluation of Sleep Changes in Inflammatory Bowel Diseases (IBD) Patients.
NARecruiting
216 participants
Started: Apr 8, 2025 · Completed: May 1, 2028
3 conditions1 sponsor4 locations
NCT06922877
Diagnostic Accuracy of 3-dimensional Imaging Device on Polyps and Adenomas During Colonoscopy
NARecruiting
450 participants
Started: Apr 8, 2025 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT06876597
Motor-Cognitive Interactive Upper Limb Robot Rehabilitation for Post-Stroke Motor Dysfunction
NARecruiting
1,047 participants
Started: Apr 8, 2025 · Completed: Dec 31, 2026
1 condition6 sponsors1 location
NCT06880679
Ultrasound Acute Chest Syndrome Sickle Cell Disease
NARecruiting
30 participants
Started: Apr 8, 2025 · Completed: Mar 1, 2026
2 conditions1 sponsor1 location
NCT06708897
A Phase 1 Study of ZE50-0134 in Relapsed and Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Select Low-grad Lymphomas
PHASE1Recruiting
66 participants
Started: Apr 8, 2025 · Completed: Apr 30, 2028
3 conditions1 sponsor4 locations
NCT06938152
Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients
PHASE4Recruiting
70 participants
Started: Apr 8, 2025 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT07087223
Phase Ib/II Study of Vebreltinib With Furmonertinib in NSCLC Patients With c-Met Amplification After EGFR-TKI Failure
PHASE1/PHASE2Recruiting
42 participants
Started: Apr 8, 2025 · Completed: Apr 30, 2028
1 condition1 sponsor12 locations
NCT06287775
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
PHASE1/PHASE2Recruiting
45 participants
Started: Apr 8, 2025 · Completed: Jul 25, 2029
2 conditions1 sponsor42 locations
NCT06857006
Trial of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases
NARecruiting
180 participants
Started: Apr 8, 2025 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT07070453
Effect of Photodynamic Therapy as an Adjunct to Non-Surgical Treatment of Periodontitis
NARecruiting
20 participants
Started: Apr 8, 2025 · Completed: Nov 30, 2025
1 condition1 sponsor2 locations
NCT06948591
BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures
N/ARecruiting
500 participants
Started: Apr 8, 2025 · Completed: Jun 30, 2030
1 condition1 sponsor1 location
NCT06786052
EXploratory Study on Postprandial Energy Metabolism
PHASE2Recruiting
66 participants
Started: Apr 7, 2025 · Completed: Feb 29, 2028
2 conditions2 sponsors1 location
NCT06809140
Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer
PHASE2Recruiting
47 participants
Started: Apr 7, 2025 · Completed: Nov 30, 2029
1 condition5 sponsors3 locations
NCT06503666
Zambian Informed Motivated Aware Responsible Adolescent Girls and Adults
NARecruiting
1,200 participants
Started: Apr 7, 2025 · Completed: May 1, 2028
2 conditions3 sponsors1 location
NCT06916702
A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men
PHASE1Recruiting
60 participants
Started: Apr 7, 2025 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT07069387
Pharmacist-led Digital Interventions to Improve Tuberculosis Treatment Adherence
NARecruiting
160 participants
Started: Apr 7, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06584409
Migraines Accepted Laser Acupuncture Compared in Blood Test of MMP2 and CGRP
NARecruiting
60 participants
Started: Apr 7, 2025 · Completed: Dec 1, 2027
1 condition1 sponsor1 location
NCT06814119
A Clinical Study of MK-1084 in Participants With Renal Impairment (MK-1084-010)
PHASE1Recruiting
30 participants
Started: Apr 7, 2025 · Completed: Nov 21, 2025
2 conditions1 sponsor2 locations
NCT06587100
Wearable Activity Tracking to Curb Hospitalizations
N/ARecruiting
260 participants
Started: Apr 7, 2025 · Completed: Dec 31, 2027
3 conditions2 sponsors1 location
NCT06384898
Remote Tai Chi for Knee Osteoarthritis
NARecruiting
480 participants
Started: Apr 7, 2025 · Completed: Aug 31, 2028
1 condition5 sponsors1 location
NCT05753683
Gathering Online for Dialogue and Discussion to Enhance Social Support
NARecruiting
500 participants
Started: Apr 7, 2025 · Completed: Apr 30, 2027
4 conditions2 sponsors1 location
NCT06849557
Chair-bound Exergaming in Pre-frail/ Frail Older Adults in Nursing Home
NARecruiting
30 participants
Started: Apr 7, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06641141
The Feasibility Of Expectant Management Versus Induction At 38 Weeks Among Individuals With Gestational Diabetes Mellitus: A Randomized Controlled Pilot Trial
NARecruiting
260 participants
Started: Apr 7, 2025 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT06919458
Short Course Steroids in Alcohol Associated Hepatitis
PHASE3Recruiting
146 participants
Started: Apr 7, 2025 · Completed: Apr 8, 2026
1 condition5 sponsors2 locations